Chemical industry – Page 3
-
ResearchTherapeutic proteins can hitch a ride on parasite to bypass blood-brain barrier
Toxoplasma could be delivery agent for protein drugs – provided parasite can be made safe
-
NewsWeight-loss drugmakers bet billions on boosting supplies
Eli Lilly and Novo Nordisk invest to expand in-house manufacturing of GLP-1 drugs
-
ResearchDrugs and vaccines could be freed from cold chains by hydrogel
Stiff gel prevents proteins from aggregating, preserving their therapeutic power
-
CareersShould I stay or should I go?
Two colleagues in academia and industry reflect on their career choices
-
NewsRed Sea attacks are reshaping chemical supply chains
High demand and reduced capacity have kept freight prices high
-
OpinionHow hoarding knowledge is hurting the industry in the long run
Sharing results that are not commercially viable would speed up research
-
ResearchPFAS from rechargeable batteries pose environmental threat
Electrolyte material used in lithium-ion batteries is highly mobile and potentially toxic
-
BusinessExplainer: How is the US pharmaceutical patent system being misused?
What are ‘evergreening’ and ‘thicketing’ and what is being done to reform the system and aid competition?
-
NewsFDA bans use of brominated vegetable oil in food and drink
Manufacturers have one year to comply as US regulator bans additive over safety concerns
-
BusinessUS Supreme Court quashes Purdue opioid bankruptcy plan
Ruling says deal cannot grant Sackler family owners protection from prosecution
-
ResearchCompanion compound for naloxone could boost opioid reversal effects, save lives
Discovery could help in fight against super-strength opioids such as fentanyl
-
BusinessInvestigation reveals multiple failures leading to fatal 2022 refinery fire
BP failed to shut down in time after ‘alarm flood’ overwhelmed operators
-
BusinessVent and burn in East Palestine train derailment was unnecessary
Safety board investigation confirms faulty wheel bearing caused crash
-
BusinessExplosion and fire at South Korean battery plant kills 23
Three company officials under investigation for potential safety violations
-
OpinionLab digitalisation and industry 4.0
How technology can help us run our labs more efficiently
-
FeatureBypassing the blood–brain barrier
Researchers are on a quest to outsmart and overcome the sophisticated security system of the brain. Julia Robinson reports on some of the approaches being studied
-
FeatureWhy don’t we know how antidepressants work yet?
Selective serotonin reuptake inhibitors are at the centre of a collision between social and biochemical outlooks on depression, finds Andy Extance
-
OpinionThe US abortion drugs regulation challenge has stalled, but it will return
Having failed in the US Supreme Court, anti-abortion activists are trying other ways to prevent access to mifepristone
-
FeatureSparking industry’s interest in electrosynthesis
Using electrons instead of reagents offers many potential benefits, but there are still barriers to overcome, as Rachel Brazil reports
-
